ACCENTIA BIOPHARMACEUTICALS INC
DelistedCIK 1310094fmd_1KNZQYKW8VZ7AN0T21K6646JFXManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Oct 01, 2009 to Sep 30, 2012, 10 periods
| Line item | FY2010 | FY2011 | FY2012 |
|---|---|---|---|
| Total revenues | 5 | 4 | 4 |
| Cost of revenue | 3 | 2 | 3 |
| Gross profit | 2 | 1 | 1 |
| Research and development | 1 | 2 | 5 |
| Selling, general and administrative | 4 | 20 | 8 |
| Total operating expenses | 6 | 23 | 13 |
| Operating income | (4) | (21) | (12) |
| Interest expense | 17 | 8 | 8 |
| Income before taxes | (47) | (16) | (12) |
| Income tax expense | 0 | 0 | – |
| Net income from continuing operations | (48) | (16) | (9) |
| Net income | (48) | (16) | (9) |
| Net income to common shareholders | (50) | (12) | (4) |